FATTORE, LUIGI
 Distribuzione geografica
Continente #
AS - Asia 380
SA - Sud America 233
NA - Nord America 32
EU - Europa 23
AF - Africa 15
Totale 683
Nazione #
BR - Brasile 187
VN - Vietnam 137
SG - Singapore 96
CN - Cina 61
KR - Corea 36
AR - Argentina 27
ID - Indonesia 21
US - Stati Uniti d'America 19
EC - Ecuador 11
HK - Hong Kong 10
MX - Messico 9
IT - Italia 8
ZA - Sudafrica 6
PY - Paraguay 5
IQ - Iraq 4
RU - Federazione Russa 4
BD - Bangladesh 3
IN - India 3
EG - Egitto 2
FR - Francia 2
GT - Guatemala 2
MA - Marocco 2
PL - Polonia 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CA - Canada 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NL - Olanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 683
Città #
Ho Chi Minh City 48
Seoul 36
Singapore 33
Hanoi 26
Beijing 13
São Paulo 11
Hong Kong 10
Haiphong 9
Mexico City 9
Guayaquil 8
Biên Hòa 6
Dallas 6
Porto Alegre 5
Rome 5
Duque de Caxias 4
Ha Long 4
Hải Dương 4
Jakarta 4
Sorocaba 4
São Bernardo do Campo 4
Belo Horizonte 3
Blumenau 3
Brasília 3
Bắc Giang 3
Catanduva 3
Curitiba 3
Da Nang 3
Guarulhos 3
Joinville 3
Rio de Janeiro 3
Thái Bình 3
Ashburn 2
Asunción 2
Atibaia 2
Can Tho 2
Cape Town 2
Catalão 2
Chapecó 2
Ciudad del Este 2
Corrientes 2
Fortaleza 2
Hortolândia 2
João Pessoa 2
New York 2
Ninh Bình 2
Osasco 2
Phủ Lý 2
Quito 2
Salvador 2
Santa Maria 2
Surakarta 2
Tashkent 2
Teresina 2
Tunis 2
Warsaw 2
Al Qāhirah al Jadīdah 1
Al'met'yevsk 1
Alausí 1
Andradas 1
Aragarças 1
Araguaína 1
Arapiraca 1
Araranguá 1
Araraquara 1
Araçatuba 1
Astana 1
Azul 1
Açailândia 1
Baghdad 1
Banyumas 1
Barbacena 1
Barcarena 1
Barra do Piraí 1
Batumi 1
Belém 1
Betim 1
Birigui 1
Boksburg 1
Brakpan 1
Brooklyn 1
Buenos Aires 1
Buritis 1
Bắc Ninh 1
Cachoeirinha 1
Cajamar 1
Camaçari 1
Casablanca 1
Cassilândia 1
Caucaia 1
Caçapava 1
Chennai 1
Colfax 1
Concepción 1
Concordia 1
Consolação 1
Council Bluffs 1
Denver 1
Don Torcuato 1
Dubai 1
Dublin 1
Totale 375
Nome #
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma 28
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions 27
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients 26
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 24
Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells 24
MirRNAs for treatment and in vitro diagnosis of drug resistant tumors 24
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer 24
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma 22
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 22
Drug tolerance to target therapy in melanoma revealed at single cell level. What next? 22
Toxicity of aflatoxin B1 towards the vitamin D receptor (VDR) 21
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors 21
C-Src recruitment is Involved in c-MET-mediated malignant behaviour of NT2D1 non-seminoma cells 21
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma 21
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma 20
Cancer stem cells and the slow cycling phenotype. how to cut the gordian knot driving resistance to therapy in melanoma 20
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin 20
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies 20
microRNA-378a-5p iS a Novel Positive Regulator of Melanoma Progression 20
Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes 20
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 20
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors 19
miR-579-3p controls melanoma progression and resistance to target therapy 19
MicroRNAs in melanoma development and resistance to target therapy 19
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung 19
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization 18
Self-assembling nanoparticles for miRNA delivery towards precision medicine against melanoma 18
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application 18
Method for predicting the development of resistance to BRAF inhibiting drugs, alone or in combination with MEK inhibiting drugs, in an anti-tumour treatment 18
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma 15
The new world of RNA diagnostics and therapeutics 14
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors 14
Selective targeting of point-mutated KRAS through artificial microRNAs 14
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin 13
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma 12
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application 10
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 9
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma 5
Totale 721
Categoria #
all - tutte 2.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202541 0 0 0 0 0 0 0 0 0 0 0 41
2025/2026680 89 24 187 270 104 6 0 0 0 0 0 0
Totale 721